Advertisement
Advertisement

TOI

TOI logo

The Oncology Institute, Inc. Common Stock

5.25
USD
Sponsored
+0.22
+4.37%
Jun 24, 16:00 UTC -4
Closed
exchange

Pre-Market

5.29

+0.04
+0.67%

TOI Earnings Reports

Positive Surprise Ratio

TOI beat 2 of 12 last estimates.

17%

Next Report

Date of Next Report
Aug 11, 2026
Estimate for Q2 26 (Revenue/ EPS)
$158.66M
/
-$0.06
Implied change from Q1 26 (Revenue/ EPS)
+7.61%
/
+200.00%
Implied change from Q2 25 (Revenue/ EPS)
+32.44%
/
-60.00%

The Oncology Institute, Inc. Common Stock earnings per share and revenue

On May 07, 2026, TOI reported earnings of -0.02 USD per share (EPS) for Q1 26, beating the estimate of -0.07 USD, resulting in a 74.46% surprise. Revenue reached 147.44 million, compared to an expected 144.67 million, with a 1.92% difference. The market reacted with a -1.72% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 4 analysts forecast an EPS of -0.06 USD, with revenue projected to reach 158.66 million USD, implying an increase of 200.00% EPS, and increase of 7.61% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
INVO Fertility, Inc. Common Stock
Report Date
Jun 22, 2026 For Q1 26
Estimate
-$1.26
Actual
-$3.38
Surprise
-167.72%
FAQ
For Q1 2026, The Oncology Institute, Inc. Common Stock reported EPS of -$0.02, beating estimates by 74.46%, and revenue of $147.44M, 1.92% above expectations.
The stock price moved down -1.72%, changed from $4.07 before the earnings release to $4.00 the day after.
The next earning report is scheduled for Aug 11, 2026.
Based on 4 analysts, The Oncology Institute, Inc. Common Stock is expected to report EPS of -$0.06 and revenue of $158.66M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement